| Recruiting | A Post-marketing Surveillance Study of Beyfortus (Nirsevimab) in Republic of Korea NCT07200206 | Sanofi | — |
| Active Not Recruiting | Phase II Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 50 Years or Abo NCT07289542 | Suzhou Abogen Biosciences Co., Ltd. | Phase 2 |
| Active Not Recruiting | STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus NCT07122661 | Pfizer | — |
| Active Not Recruiting | A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) NCT07117487 | ModernaTX, Inc. | Phase 3 |
| Active Not Recruiting | Phase I Clinical Trial of Lyophilized Respiratory Syncytial Virus mRNA Vaccine in Adults Aged 18 Years or Abov NCT07289503 | Suzhou Abogen Biosciences Co., Ltd. | Phase 1 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Respiratory Syncytial Virus NCT06754605 | Sinocelltech Ltd. | Phase 1 / Phase 2 |
| Completed | A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Older Adults in Korea NCT06593587 | Pfizer | Phase 3 |
| Active Not Recruiting | Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy NCT06647654 | Pfizer | — |
| Recruiting | Assessing Antiviral Treatments in Early Symptomatic RSV NCT06488300 | University of Oxford | Phase 2 |
| Completed | BEYFORTUS™ (Nirsevimab) Effectiveness Against Medically-Attended RSV Events in Infants (BEAR Study) NCT06325332 | Sanofi Pasteur, a Sanofi Company | — |
| Completed | A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants NCT06325657 | Pfizer | Phase 3 |
| Active Not Recruiting | A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Va NCT06143046 | ModernaTX, Inc. | Phase 2 |
| Completed | A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age NCT06097299 | ModernaTX, Inc. | Phase 2 |
| Active Not Recruiting | A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Viru NCT06067230 | ModernaTX, Inc. | Phase 3 |
| Completed | A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Vir NCT06060457 | ModernaTX, Inc. | Phase 3 |
| Active Not Recruiting | A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to < NCT05743881 | ModernaTX, Inc. | Phase 1 |
| Completed | Respiratory Syncytial Virus (RSV) Human Challenge Study of Molnupiravir in Healthy Participants (MK-4482-017) NCT05559905 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study NCT05572658 | ModernaTX, Inc. | — |
| Completed | A Study of Modified mRNA Vaccines in Healthy Adults NCT05397223 | ModernaTX, Inc. | Phase 1 |
| Completed | Safety and Immunogenicity of RSVpreF Coadministered With SIIV in Adults ≥65 Years of Age NCT05301322 | Pfizer | Phase 3 |
| Completed | A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age NCT05330975 | ModernaTX, Inc. | Phase 3 |
| Completed | A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) i NCT05127434 | ModernaTX, Inc. | Phase 2 / Phase 3 |
| Terminated | A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection NCT04978337 | Janssen Research & Development, LLC | Phase 2 |
| Completed | A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults NCT04528719 | ModernaTX, Inc. | Phase 1 |
| Completed | A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncyt NCT04196101 | Enanta Pharmaceuticals, Inc | Phase 2 |
| Completed | A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory NCT03606512 | Janssen Vaccines & Prevention B.V. | Phase 1 / Phase 2 |
| Completed | Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002) NCT03524118 | Merck Sharp & Dohme LLC | Phase 1 / Phase 2 |
| Completed | Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSV NCT03049488 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respi NCT02707523 | University of Alabama at Birmingham | Phase 2 |
| Terminated | A Study to Evaluate the Efficacy of MEDI7510 in Older Adults NCT02508194 | MedImmune LLC | Phase 2 |
| Completed | A Study to Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine NCT02472548 | Dalhousie University | Phase 1 |
| Completed | Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper NCT02254408 | Gilead Sciences | Phase 2 |
| Completed | A Phase 1b/2a Randomized, Double-Blind, Placebo-controlled, Dose-escalation Study to Evaluate the Safety, Tole NCT02290340 | MedImmune LLC | Phase 1 |
| Completed | A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, S NCT01995175 | GlaxoSmithKline | N/A |
| Completed | A Study in Belgian Children Hospitalized With Respiratory Syncytial Virus Related Acute Respiratory Infections NCT02133092 | Janssen Research & Development, LLC | — |
| Completed | A Study in Japanese Children Hospitalized With Respiratory Syncytial Virus Related Lower Respiratory Tract Inf NCT02132923 | Janssen R&D Ireland | — |
| Terminated | Cough Assist in Bronchiolitis NCT01757496 | University Hospital, Antwerp | N/A |
| Completed | MEDI-557 Adult Dosing NCT01562938 | MedImmune LLC | Phase 1 |
| Completed | Sofia RSV FIA Field Study NCT01734668 | Quidel Corporation | — |
| Completed | Respiratory Events Among Premature Infants NCT00889070 | MedImmune LLC | — |
| Unknown | Comparison of Nylon Flocked Swabs and Saline Aspirates for Detection Respiratory Viruses NCT00613184 | Kern Medical Center | N/A |
| Completed | RSV Disease in the Elderly NCT00246480 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | RSV Challenge in Healthy Adults NCT00100373 | National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
| No Longer Available | Pre-Approval Access to JNJ-53718678 for the Treatment of Respiratory Syncytial Virus (RSV) Infection in (a) Im NCT04221412 | Janssen Sciences Ireland UC | — |